Yongqian Liang

机构：Guangdong Pharmaceutical University, Institute of Plant Protection, The First People's Hospital of Shunde, China Agricultural University

发表论文 32 篇 · 总被引 379 次 · h-index 10

代表论文

• Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial (2022 · Nature Medicine · 被引 76)
• The effect of dietary carbohydrate and calorie restriction on weight and metabolic health in overweight/obese individuals: a multi-center randomized controlled trial (2023 · BMC Medicine · 被引 54)
• Central Sensitivity to Free Triiodothyronine With MAFLD and Its Progression to Liver Fibrosis in Euthyroid Adults (2023 · The Journal of Clinical Endocrinology & Metabolism · 被引 36)
• Associations of phthalates with NAFLD and liver fibrosis: A nationally representative cross-sectional study from NHANES 2017 to 2018 (2022 · Frontiers in Nutrition · 被引 30)
• Silymarin decreases liver stiffness associated with gut microbiota in patients with metabolic dysfunction-associated steatotic liver disease: a randomized, double-blind, placebo-controlled trial (2024 · Lipids in Health and Disease · 被引 27)
• Association of multiple blood metals with thyroid function in general adults: A cross−sectional study (2023 · Frontiers in Endocrinology · 被引 17)